Endovia Health Sciences Capital Raise
Endovia Health Sciences entered into an addendum to its existing equity line of credit (ELOC) with C/M Capital Master Fund, LP, increasing the maximum commitment from $35 million to $135 million. The agreement allows the company to sell and issue shares of common stock to the fund from time to time, providing a significant increase in potential liquidity. The addendum also updates terms for sales exceeding the initial 10.875 million shares issued under the original facility.
- Counterparty
- C/M Capital Master Fund, LP